Biofrontera Inc. (BFRI): Nasdaq/NYSE listing notice — Biofrontera receives Nasdaq deficiency notice for equity below $2.5M

Biofrontera Inc.

Stockholders' equity at $469,000, well below Nasdaq's $2.5M minimum requirement.
Company has 45 days to submit a compliance plan to Nasdaq.
If plan accepted, Nasdaq may grant up to 180 days from May 21, 2025 to regain compliance.
Alternative market value or net income criteria also not met.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Biofrontera Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1), 5550(b)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1), 5550(b)

Exact text from the filing

May 21, 2025, Biofrontera Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, because the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the period ended March 31, 2025 was $469,000, the Company is no longer in compliance with the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company’s stockholders’ equity be at least $2,500,000. Additionally, as of the date of the Notice, the Company did not meet either of the alternative requirements of

View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Biofrontera Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-012285

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.